Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
    • Access insights
    • Health Equity through Her Lens
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Beth Boyer to speak at Medicine Quality & Public Health conference in Oxford

On 27 September, Beth Boyer, Researcher at the Access to Medicine Foundation, will join the Medicine Quality & Public Health Conference in Oxford to present the work of the Foundation on evaluating how pharmaceutical companies make high-quality medicines available and accessible in low- and middle-income countries. 

Date

27 September 2018

This academic event is organised by University of Oxford, Infectious Diseases Data Observatory, Nuffield Department of Medicine and Wellcome Trust to bring together experts from public health, national regulatory authorities, pharmacy, biomedical, chemistry, law, ethics, cultural and social sciences, the pharmaceutical industry, international organisations, NGOs, national procurement centres, and internet and pharmaceutical forensics. 

Beth will highlight key findings from Access to Medicine Index on pharmaceutical company actions to improve access to quality medicines. She will also share some examples of best practices in capacity building and innovations identified by the Foundation’s research team throughout the past 10 years. The diffusion of best practices is one of the Access to Medicine Foundation’s mechanisms for supporting the pharmaceutical industry to achieve greater access to medicine. The next Access to Medicine Index will be published in November 2018.

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved